公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 BIOSYS LTDA取消

83 记录

产品持有公司班级有效性
Família ichroma iFOB Neo10350840434BIOSYS LTDAIII27/03/2033
Ichroma Tn-I Plus10350840348BIOSYS LTDAIII25/03/2029
Immunosuppressants Whole Blood Control, Four- Level (I+II+III+IV)10350840239BIOSYS LTDAIII30/12/2033
Internal Standard Set - MassTox Immunosuppressants in Whole Blood10350840441BIOSYS LTDAIII02/01/2034
MasCheck Amino acids, acylcarnitines incl. succinylacetone dried blood spot control, bi-Level (I+II)10350840187BIOSYS LTDAIII23/06/2035
MassChrom Amino acids and acylcarnitines from dried blood10350840260BIOSYS LTDAIII22/12/2034
MassChrom Amino acids and acylcarnitines from dried blood - Derivatised10350840263BIOSYS LTDAIII02/02/2035
MassTox Immunosuppressants in whole blood10350840243BIOSYS LTDAIII31/03/2034
Metanephrines Urine Calibration Standard10350840336BIOSYS LTDAIII13/04/2036
Metanephrines in Urine HPLC10350840132BIOSYS LTDAIII13/07/2036
SGTi-flex Dengue Ab & Ag Duo10350840491BIOSYS LTDAIII05/01/2036
SGTi-flex Dengue IgM/IgG10350840485BIOSYS LTDAIII01/09/2035
SGTi-flex Dengue NS1 Ag10350840483BIOSYS LTDAIII04/08/2035
TEMPO DE PROTROMBINA (TP)80367750183BIOSYSTEMS NE COMÉRCIO DE PRODUTOS LABORATORIAIS E HOSPITALARES LTDAIII20/04/2035
TEMPO DE TROMBOPLASTINA PARCIAL ATIVADA (TTPA)80367750181BIOSYSTEMS NE COMÉRCIO DE PRODUTOS LABORATORIAIS E HOSPITALARES LTDAIII01/06/2035
Tricyclic Antidepressants plasma controls Bi-Level (I+II)10350840262BIOSYS LTDAIII24/11/2035
VISITECT CD4 Advanced Disease10350840408BIOSYS LTDAIII07/06/2031
i-CHROMA Tn-I Neo10350840278BIOSYS LTDAIII21/12/2035
ichroma CA12510350840472BIOSYS LTDAIII05/03/2035
ichroma CK-MB Neo10350840277BIOSYS LTDAIII14/12/2035
ichroma COVID-19 Ab10350840365BIOSYS LTDAIII27/04/2030
ichroma COVID-19 Ag10350840369BIOSYS LTDAIII13/07/2030
ichroma COVID-19/Flu Ag Combo10350840416BIOSYS LTDAIII07/02/2032
ichroma Cardiac Triple10350840401BIOSYS LTDAIII03/05/2031
ichroma D-Dimer Neo10350840279BIOSYS LTDAIII28/12/2035

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家